Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Melnikow

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Annals of Internal Medicine|March 17, 2010
ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomesJoy Melnikow
Evidence-Based Medicine|December 8, 2007
Review: vaccines against human papillomavirus prevent cervical cancer precursors in young women for at least 3 yearsJoy Melnikow
Journal of the National Cancer Institute|January 19, 2006
Human papillomavirus triage of atypical squamous cells of undetermined significance: cost-effective, but at what cost?Joy Melnikow, Stephen Birch
American Family Physician|October 16, 2023
The Community Preventive Services Task Force: A Useful Resource for Family PhysiciansJoy Melnikow, Kathryn L Istas
JAMA Internal Medicine|June 25, 2019
Digital Breast Tomosynthesis-Diffusion Into Practice Preceding EvidenceJoy Melnikow, Joshua J Fenton
Medical Care|April 13, 2004
Medical adherence research: time for a change in direction?Richard L Kravitz, Joy Melnikow
BMC Health Services Research|March 19, 2022
Frontline physician burnout during the COVID-19 pandemic: national survey findingsJoy Melnikow, Andrew Padovani, Marykate Miller
JAMA|June 1, 2002
Reporting number needed to treat and absolute risk reduction in randomized controlled trialsJim Nuovo, Joy Melnikow, Denise Chang
Health Economics|September 26, 2003
Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utilityStephen Birch, Joy Melnikow, Miriam Kuppermann
Health Economics|August 25, 2006
Do personal and societal preferences differ by socio-demographic group?Peter Franks, Erica I Lubetkin, Joy Melnikow
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Annals of Internal Medicine|March 17, 2010
ACP Journal Club. Review: Tamoxifen, raloxifene, and tibolone prevent primary invasive breast cancer but increase risk for adverse outcomesJoy Melnikow
Evidence-Based Medicine|December 8, 2007
Review: vaccines against human papillomavirus prevent cervical cancer precursors in young women for at least 3 yearsJoy Melnikow
Journal of the National Cancer Institute|January 19, 2006
Human papillomavirus triage of atypical squamous cells of undetermined significance: cost-effective, but at what cost?Joy Melnikow, Stephen Birch
American Family Physician|October 16, 2023
The Community Preventive Services Task Force: A Useful Resource for Family PhysiciansJoy Melnikow, Kathryn L Istas
JAMA Internal Medicine|June 25, 2019
Digital Breast Tomosynthesis-Diffusion Into Practice Preceding EvidenceJoy Melnikow, Joshua J Fenton
Medical Care|April 13, 2004
Medical adherence research: time for a change in direction?Richard L Kravitz, Joy Melnikow
BMC Health Services Research|March 19, 2022
Frontline physician burnout during the COVID-19 pandemic: national survey findingsJoy Melnikow, Andrew Padovani, Marykate Miller
JAMA|June 1, 2002
Reporting number needed to treat and absolute risk reduction in randomized controlled trialsJim Nuovo, Joy Melnikow, Denise Chang
Health Economics|September 26, 2003
Conservative versus aggressive follow up of mildly abnormal Pap smears: testing for process utilityStephen Birch, Joy Melnikow, Miriam Kuppermann
Health Economics|August 25, 2006
Do personal and societal preferences differ by socio-demographic group?Peter Franks, Erica I Lubetkin, Joy Melnikow
Pageof 9